Accelarated immune ageing is associated with COVID-19 disease severity. (2024)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12979-023-00406-z
PubMed Identifier: 38212801
Publication URI: http://europepmc.org/abstract/MED/38212801
Type: Journal Article/Review
Volume: 21
Parent Publication: Immunity & ageing : I & A
Issue: 1
ISSN: 1742-4933